Search research articles
Contact Us
Filters
Showing results (61-70 of 115) with videos related to
Page
of 12
Sort By:
The Prostate
|
February 2, 2013
Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancer
Farshid Dayyani, Andreas Varkaris, John C Araujo, et al.
International Journal of Cancer
|
March 26, 2013
Ligand-independent activation of MET through IGF-1/IGF-1R signaling
Andreas Varkaris, Sanchaika Gaur, Nila U Parikh, et al.
Cancers
|
May 5, 2021
Immunotherapy Updates in Advanced Hepatocellular Carcinoma
Amisha Singh, Ryan J Beechinor, Jasmine C Huynh, et al.
The Journal of Surgical Research
|
May 25, 2024
Clinical Outcomes in Patients With Krukenberg Tumors From Colorectal Cancer
Arsha Ostowari, Bima J Hasjim, Leena Lim, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
July 9, 2026
Outcomes of Irreversible Electroporation for Treatment of Refractory Locally Advanced Pancreatic Cancer
Ricardo Azevedo, David Imagawa, Marianne Rara, et al.
Journal of Hepatocellular Carcinoma
|
May 27, 2021
Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma
Nadine Abi-Jaoudeh, Farshid Dayyani, Pei Jer Chen, et al.
The American Journal of Case Reports
|
June 29, 2023
Endometrial Adenocarcinoma with Discordant Microsatellite Stability Status Treated with First-Line Pembrolizumab: A Case Report and Narrative Review
Christopher R Grant, Elaine J Chiao, Zhaohui L Arter, et al.
Cancer Medicine
|
December 5, 2025
Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervised Machine Learning Approach
Garrett K Harada, Jino Park, Nicholas Peterson, et al.
Future Oncology (London, England)
|
May 4, 2026
Impact of <i>UGT1A1*28</i> polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial
Maen Abdelrahim, Gazala Khan, Hassan Hatoum, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung
Thomas Muley, Ying He, Vinzent Rolny, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 115) with videos related to
Sort By:
Page
of 12
The Prostate
|
February 2, 2013
Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancer
Farshid Dayyani, Andreas Varkaris, John C Araujo, et al.
International Journal of Cancer
|
March 26, 2013
Ligand-independent activation of MET through IGF-1/IGF-1R signaling
Andreas Varkaris, Sanchaika Gaur, Nila U Parikh, et al.
Cancers
|
May 5, 2021
Immunotherapy Updates in Advanced Hepatocellular Carcinoma
Amisha Singh, Ryan J Beechinor, Jasmine C Huynh, et al.
The Journal of Surgical Research
|
May 25, 2024
Clinical Outcomes in Patients With Krukenberg Tumors From Colorectal Cancer
Arsha Ostowari, Bima J Hasjim, Leena Lim, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
July 9, 2026
Outcomes of Irreversible Electroporation for Treatment of Refractory Locally Advanced Pancreatic Cancer
Ricardo Azevedo, David Imagawa, Marianne Rara, et al.
Journal of Hepatocellular Carcinoma
|
May 27, 2021
Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma
Nadine Abi-Jaoudeh, Farshid Dayyani, Pei Jer Chen, et al.
The American Journal of Case Reports
|
June 29, 2023
Endometrial Adenocarcinoma with Discordant Microsatellite Stability Status Treated with First-Line Pembrolizumab: A Case Report and Narrative Review
Christopher R Grant, Elaine J Chiao, Zhaohui L Arter, et al.
Cancer Medicine
|
December 5, 2025
Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervised Machine Learning Approach
Garrett K Harada, Jino Park, Nicholas Peterson, et al.
Future Oncology (London, England)
|
May 4, 2026
Impact of <i>UGT1A1*28</i> polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial
Maen Abdelrahim, Gazala Khan, Hassan Hatoum, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung
Thomas Muley, Ying He, Vinzent Rolny, et al.
Page
of 12